Birmingham Hip Resurfacing or BHR hip medical devises have a seven year revision rate of 11.76, well above the normal acceptable failure rate for this type of medical device. Similar data compiled by the National Joint Replacement Registry of Australia in 2015 show the BHR has a ten-year revision rate of 14.5 percent for women. Other studies place the failure rate for women as high as 26 percent.
The problems associated with the BHR and the R3 liner is similar to the injuries caused by other metal-on-metal hip devices.
The BHR device consists of a femoral head component and a hemispherical acetabular cup that is made in a range of 12 sizes. The cup fits into the patient’s hip socket, or acetabulum, and then rubs against the femoral head during articulation (movement) of the patient’s hip joint. Both components are made of cobalt and chromium metal alloys, and thus are “metal-on-metal” hip implant components.
Over time, the movement of the metal components inside the hip joint leads to tiny particles of metal being shed into the patient’s hip joint and body, which in many cases leads to bone and tissue necrosis, toxic damage and the formation of pseudo tumors.
Smith & Nephew Hip Implant Recalls
The BHR may be used as part of a hip resurfacing, or it may be combined with a femoral stem in a total hip arthroplasty. The U.S. Food and Drug Administration (“FDA”) approved the BHR for sale in the U.S. on May 9, 2006, through the Premarket Approval (“PMA”) process for Class III medical devices. The R3 system consists of a femoral head and cup, with a metal acetabular liner separating the two components. These two devices share a similar mechanism of failure, and the FDA initially approved the R3 to be used as part of the BHR system. Smith & Nephew recalled the R3 in June 2012 due to high failure rates. The company later withdrew the BHR device from the U.S. market in June 2015 due to similar high failure rates, particularly in women and in patients with smaller hip joints.
For many patients, the only remedy is to have the BHR or R3 device surgically removed in a surgery called a revision. It can cost well over $100,000 in additional medical expenses to have the BHR hip device surgically removed including physical therapy and long term follow up care.
Smith and Nephew hip implant models
· Smith & Nephew Birmingham· Smith & Nephew Emperion· Smith & Nephew R3 Acetabular (2012 recall)
How do I Preserve My Claim?
It is important that you contact a experienced personal injury Attorney as soon as possible due to the short statute of limitation to bring these types of medical device lawsuits. For a free evaluation of your BHR or R3 Smith & Nephew hip implant recall case, contact Attorneys Everett Pepper, Daniel Jones, or Chris Odom at 601-202-1111.